Hàn Quốc cấp phép khẩn cấp thuốc molnupiravir điều trị COVID-19

Trong nỗ lực giảm ca bệnh nặng và tử vong do COVID-19, cơ quan an toàn dược phẩm của Hàn Quốc ngày 23/3 đã cấp phép khẩn cấp thuốc molnupiravir của hãng Merck & Co Inc để điều trị cho người trưởng thành mắc COVID-19.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

EC thông qua nghị quyết thành lập “Schengen quân sự”

EC thông qua nghị quyết thành lập “Schengen quân sự”

Thế giới
(Baothanhhoa.vn) - Nghị viện châu Âu (EC) đã thông qua một nghị quyết quan trọng kêu gọi thành lập khu vực mang tên “Schengen quân sự”, nhằm tạo điều kiện cho lực lượng vũ trang và các trang thiết bị quân sự của Liên minh châu Âu (EU) có thể di chuyển tự do, nhanh...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh